{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:27:54Z","timestamp":1794547674925,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yexcr.2026.115210","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:58:54Z","timestamp":1792421934000},"page":"115210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["BIRC3 promotes BYSL ubiquitination and degradation and attenuates WNT\/\u03b2-catenin signaling and malignant phenotypes in lung squamous cell carcinoma"],"prefix":"10.1016","volume":"463","author":[{"given":"Jianyi","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangmao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2026.115210_bib1","article-title":"FHL2 facilitates LUSC growth and therapy resistance through PI3K\/AKT\/mTOR activation","volume":"301","author":"Zhang","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2026.115210_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccell.2022.11.015","article-title":"KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition","volume":"41","author":"Pan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2026.115210_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3324\/haematol.2019.238691","article-title":"BIRC3 mutations in chronic lymphocytic leukemia - uncommon and unfavorable","volume":"105","author":"Tausch","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.yexcr.2026.115210_bib4","first-page":"151","article-title":"Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro","volume":"566","author":"Park","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2026.115210_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13046-018-0985-y","article-title":"Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115210_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13578-020-00521-0","article-title":"BIRC3 and BIRC5: multi-faceted inhibitors in cancer","volume":"11","author":"Frazzi","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.yexcr.2026.115210_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.965708","article-title":"ATF6\u03b1 contributes to rheumatoid arthritis by inducing inflammatory cytokine production and apoptosis resistance","volume":"13","author":"Ge","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115210_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10565-025-10045-3","article-title":"cIAP2-mediated IGF2BP2 ubiquitination and degradation regulate cardiomyocyte apoptosis via stabilizing m(6)A-modified BAX mRNA in myocardial infarction","volume":"41","author":"Wang","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.yexcr.2026.115210_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12024-017-9942-x","article-title":"Bystin (BYSL) as a possible marker of severe hypoxic-ischemic changes in neuropathological examination of forensic cases","volume":"14","author":"Olczak","year":"2018","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.yexcr.2026.115210_bib10","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/cr.2009.99","article-title":"Bystin-like protein is upregulated in hepatocellular carcinoma and required for nucleologenesis in cancer cell proliferation","volume":"19","author":"Wang","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.yexcr.2026.115210_bib11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/PGP.0b013e318275a550","article-title":"Developmentally restricted differentiation antigens are targets for immunotherapy in epithelial ovarian carcinoma","volume":"32","author":"Godoy","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.yexcr.2026.115210_bib12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/pros.20323","article-title":"Bystin in perineural invasion of prostate cancer","volume":"66","author":"Ayala","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.yexcr.2026.115210_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.565225","article-title":"BYSL promotes glioblastoma cell migration, invasion, and mesenchymal transition through the GSK-3\u03b2\/\u03b2-Catenin signaling pathway","volume":"10","author":"Sha","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2026.115210_bib14","article-title":"Hypoxia-induced miR-378a-3p inhibits osteosarcoma invasion and epithelial-to-mesenchymal transition via BYSL regulation","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.yexcr.2026.115210_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4274\/balkanmedj.galenos.2022.2022-6-16","article-title":"COL3A1 overexpression associates with poor prognosis and Cisplatin resistance in lung cancer","volume":"39","author":"Wang","year":"2022","journal-title":"Balkan Med. J."},{"key":"10.1016\/j.yexcr.2026.115210_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41420-024-01975-8","article-title":"TM7SF2-induced lipid reprogramming promotes cell proliferation and migration via CPT1A\/Wnt\/\u03b2-Catenin axis in cervical cancer cells","volume":"10","author":"Liu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.yexcr.2026.115210_bib17","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1038\/s41598-021-86847-2","article-title":"Mitochondrial LonP1 protease is implicated in the degradation of unstable Parkinson's disease-associated DJ-1\/PARK 7 missense mutants","volume":"11","author":"S\u00e1nchez-Lanzas","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2026.115210_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1204","article-title":"The roles of E3 ubiquitin ligases in cancer progression and targeted therapy","volume":"13","author":"Sampson","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115210_bib19","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","article-title":"Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells","volume":"13","author":"Tan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115210_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01112-24","article-title":"DCLK1 mediated cooperative acceleration of EMT by avian leukosis virus subgroup J and Marek's disease virus via the Wnt\/\u03b2-catenin pathway promotes tumor metastasis","volume":"98","author":"Zhou","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2026.115210_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.yexcr.2026.115210_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-Catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2026.115210_bib23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/2767-9764.CRC-25-0052","article-title":"The XPO1 inhibitor eltanexor modulates the Wnt\/\u03b2-Catenin signaling pathway to reduce colorectal cancer tumorigenesis","volume":"5","author":"Evans","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.yexcr.2026.115210_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biology14020194","article-title":"Modulation of Wnt\/beta-catenin pathway by major dietary phytochemicals against breast cancer development","volume":"14","author":"Lieb","year":"2025","journal-title":"Biology"},{"key":"10.1016\/j.yexcr.2026.115210_bib25","doi-asserted-by":"crossref","DOI":"10.3892\/or.2022.8404","article-title":"Wnt2b and Wnt5a expression is highly associated with M2 TAMs in non-small cell lung cancer","volume":"48","author":"Sumitomo","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2026.115210_bib26","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.7150\/jca.18560","article-title":"Wnt3a expression is associated with epithelial-mesenchymal transition and impacts prognosis of lung adenocarcinoma patients","volume":"8","author":"Xu","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.yexcr.2026.115210_bib27","article-title":"Wnt\/\u03b2-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma","volume":"14","author":"Ding","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2026.115210_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115210_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1220108","article-title":"The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer","volume":"14","author":"Ye","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.yexcr.2026.115210_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726003277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726003277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:07:33Z","timestamp":1794546453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726003277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0014482726003277"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115210","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BIRC3 promotes BYSL ubiquitination and degradation and attenuates WNT\/\u03b2-catenin signaling and malignant phenotypes in lung squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115210"}}